Schroder Investment Management Group’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-11,876
| Closed | -$87.8K | – | 1257 |
|
|
2024
Q4 | $87.8K | Sell |
11,876
-3,421
| -22% | -$25.3K | ﹤0.01% | 1186 |
|
|
2024
Q3 | $101K | Buy |
+15,297
| New | +$101K | ﹤0.01% | 1180 |
|
|
2023
Q2 | – | Sell |
-131,803
| Closed | -$879K | – | 1277 |
|
|
2023
Q1 | $879K | Sell |
131,803
-28,161
| -18% | -$188K | ﹤0.01% | 1069 |
|
|
2022
Q4 | $1.23M | Buy |
159,964
+51,119
| +47% | +$394K | ﹤0.01% | 1027 |
|
|
2022
Q3 | $1.16M | Buy |
+108,845
| New | +$1.16M | ﹤0.01% | 1030 |
|